Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses

Personalized cancer therapy targeting somatic mutations in patient tumors is increasingly being incorporated into practice. Other therapeutic vulnerabilities resulting from changes in gene expression due to tumor specific epigenetic perturbations are progressively being recognized. These genomic and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell
Main Authors: Stewart, Elizabeth, McEvoy, Justina, Wang, Hong, Chen, Xiang, Honnell, Victoria, Ocarz, Monica, Gordon, Brittney, Dapper, Jason, Blankenship, Kaley, Yang, Yanling, Li, Yuxin, Shaw, Timothy I., Cho, Ji-Hoon, Wang, Xusheng, Xu, Beisi, Gupta, Pankaj, Fan, Yiping, Liu, Yu, Rusch, Michael, Griffiths, Lyra, Jeon, Jongrye, Freeman, Burgess B., Clay, Michael R., Pappo, Alberto, Easton, John, Shurtleff, Sheila, Shelat, Anang, Zhou, Xin, Boggs, Kristy, Mulder, Heather, Yergeau, Donald, Bahrami, Armita, Mardis, Elaine R., Wilson, Richard K., Zhang, Jinghui, Peng, Junmin, Downing, James R., Dyer, Michael A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6158019/
https://ncbi.nlm.nih.gov/pubmed/30146332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2018.07.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados